Joe - ChimeraResearchGroup· @ChimeraResearch · X·· 2026-04-21Score60
Body
$MDNAF $MDNA.to outstanding data MDNA113 in NHP presented at #AACR26
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026
Heat 14 · 12 likes · 0 replies · 2 reposts
Conference abstracts
4342matched by 代号 MDNA113
MDNA113 is a masked conditionally activated tumor-targeted anti-PD1-IL-2SK with superior safety and therapeutic propertiesMinh D. To, Rosemina Merchant, Aanchal Sharma, Fahar Merchant
Read the abstract →Source: Joe - ChimeraResearchGroup · x.com
